← SynDRA
PIPENZOLATE
SynDRA canonical compound SYN0025744 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | CHRM1 |
|---|
| Mechanism of action | Cholinergic receptor antagonist |
|---|
| Indication | spasms |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Cholinergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRM3
- KCNH2
- CHRM2
- OPRM1
- HTR2C
- HTR3A
- KDM4A
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- ADORA1
- HTR2A
- PDE3A
- PDE4D
- PGR
- PTGS2
- RAB9A
- SAMHD1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- TBXA2R
- HTR2B
- HTR1A
- ADORA2A
- CCKBR
- ADORA3
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- ACM4
- ACM5
- CP2D6
- IFNG
- INS
ATC classes
- A03A · DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
- ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
Cross-references
Synonyms
- pipenzolate bromide
- Pipenzolate cation
- Pipenzolate ion
- RS3K5YXV34
- RefChem:174382
- DTXCID5028455
- 1-Ethyl-1-methyl-3-(oxidodiphenylacetoxy)piperidinium
- Pipenzolonum
- EINECS 236-748-1
- UNII-RS3K5YXV34
- BRN 1506094
- Spectrum_001304
- Prestwick0_000760
- Prestwick1_000760
- Prestwick2_000760
- Prestwick3_000760
- Spectrum2_001514
- Spectrum3_001546
- Spectrum4_000754
- Spectrum5_001065
- BSPBio_000780
- BSPBio_002992
- KBioGR_001108
- KBioSS_001784
- PIPENZOLATE [WHO-DD]
- 5-21-01-00043 (Beilstein Handbook Reference)
- DivK1c_000638
- SPBio_001587
- SPBio_002719
- BPBio1_000858
- SCHEMBL25957021
- CHEBI:95178
- KBio1_000638
- KBio2_001784
- KBio2_004352
- KBio2_006920
- KBio3_002492
- NINDS_000638
Look up PIPENZOLATE in the interactive SynDRA portal →